# Switching dmd

**URL:** <https://forum.mssociety.org.uk/t/switching-dmd/77940>\
**Category:** Symptoms and treatments\
**Created:** [26 November 2024 14:05 UTC](https://forum.mssociety.org.uk/t/switching-dmd/77940 "2024-11-26T14:05:44Z")\
**Posts on this page:** 3\
**Page:** 1

<div class="post-metadata">

**Author:** ![AAJM](https://avatars.discourse-cdn.com/v4/letter/a/8edcca/32.png) [@AAJM](https://forum.mssociety.org.uk/u/AAJM)\
**Post date:** [26 November 2024 14:05 UTC](https://forum.mssociety.org.uk/t/switching-dmd/77940/1 "2024-11-26T14:05:44Z")

</div>

Hi all, just wondering for some opinions on ocrevus or kesimpta since I’ve been told I’m moving onto one of these drugs from Tysabri.

---

<div class="post-metadata">

**Author:** ![RC\_Bristol](https://avatars.discourse-cdn.com/v4/letter/r/7cd45c/32.png) [@RC\_Bristol](https://forum.mssociety.org.uk/u/RC_Bristol)\
**Post date:** [27 November 2024 21:41 UTC](https://forum.mssociety.org.uk/t/switching-dmd/77940/3 "2024-11-27T21:41:06Z")

</div>

In terms of reducing relapse rate my understanding is they are very similar performance wise. If it were me I would choose Kesimpta as My interpretation is it carries a lower risk of cancer.

---

<div class="post-metadata">

**Author:** ![Leonora](https://avatars.discourse-cdn.com/v4/letter/l/7bcc69/32.png) [@Leonora](https://forum.mssociety.org.uk/u/Leonora)\
**Post date:** [29 November 2024 19:16 UTC](https://forum.mssociety.org.uk/t/switching-dmd/77940/4 "2024-11-29T19:16:18Z")

</div>

I’m on Kesimpta, fine so far (11 months). For me, the main advantage of Kesimpta over Ocrevus was being able to self-administer. I’d fine it a real pain to have to attend hospital for infusions. Less time spent in hospitals the better!
